Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Cancers|June 2, 2021
The Ubiquitin Proteasome System in Genome Stability and CancerJonathan J Morgan, Lisa J CrawfordInternational Journal of Molecular Sciences|February 10, 2019
TRAF6 Silencing Attenuates Multiple Myeloma Cell Adhesion to Bone Marrow Stromal CellsJonathan J Morgan, Roisin M McAvera, Lisa J CrawfordScientific Reports|April 16, 2024
TRIM33 loss in multiple myeloma is associated with genomic instability and sensitivity to PARP inhibitorsRoisin M McAvera, Jonathan J Morgan, Ana B Herrero, et al.Blood Reviews|November 5, 2013
Targeting the ubiquitin proteasome system in haematological malignanciesLisa J Crawford, Alexandra E IrvineMethods in Molecular Biology (Clifton, N.J.)|October 14, 2016
Separation and Enrichment of Hematopoietic Stem Cells for CCN StudiesLisa J Crawford, Alexandra E IrvineJournal of Cell Communication and Signaling|April 13, 2011
Proteasome inhibitors in cancer therapyLisa J Crawford, Brian Walker, Alexandra E IrvineJournal of Cell Communication and Signaling|November 8, 2017
TRIM proteins in blood cancersLisa J Crawford, Cliona K Johnston, Alexandra E IrvineOncogene|June 12, 2020
The E3 ligase HUWE1 inhibition as a therapeutic strategy to target MYC in multiple myelomaLisa J Crawford, David C Campbell, Jonathan J Morgan, et al.Oncotarget|September 23, 2016
Identification of the APC/C co-factor FZR1 as a novel therapeutic target for multiple myelomaLisa J Crawford, Gordon Anderson, Cliona K Johnston, et al.Pageof 2